Name | 3-(3-oxo-4-propylquinoxalin-2-yl)propyl N-methylcarbamate |
---|---|
Synonyms |
bamaquimast
Bamaquimast [INN] 3-(3-Oxo-4-propyl-3,4-dihydro-2-quinoxalinyl)propyl methylcarbamate 3-(3-Hydroxypropyl)-1-propyl-2(1H)-quinoxalinone Methylcarbamate (Ester) 2(1H)-Quinoxalinone,3-[3-[[(methylamino)carbonyl]oxy]propyl]-1-propyl Baquimast 2(1H)-Quinoxalinone, 3-[3-[[(methylamino)carbonyl]oxy]propyl]-1-propyl- 1-propyl 3-(3-methylcarbamoyloxy propyl) 1,2-dihydro 2-oxo quinoxaline 3-(3-oxo-4-propyl-3,4-dihydroquinoxalin-2-yl)propyl methylcarbamate |
Description | Bamaquimast is an inhibitor of proton pump extracted from patent US2005165041, example 138. |
---|---|
Related Catalog |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C16H21N3O3 |
Molecular Weight | 303.356 |
Exact Mass | 303.158295 |
PSA | 76.71000 |
LogP | 1.73 |
Appearance | white solid |
Index of Refraction | 1.579 |
Storage condition | -20℃ |
~% 135779-82-7 |
Literature: Pierre Fabre Medicament Patent: US5198441 A1, 1993 ; |
Precursor 1 | |
---|---|
DownStream 0 |